Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × INDUSTRY × Lymphopenia × Clear all

Phase

Status

Sponsor Class

OTHER 4 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 592 Breast Neoplasms 507 Neoplasms 397 Colorectal Neoplasms 261 Prostatic Neoplasms 235 Neoplasm Metastasis 231 Melanoma 213 Ovarian Neoplasms 191 Recurrence 185 Lung Neoplasms 170 Multiple Myeloma 165 Pancreatic Neoplasms 138 Lymphoma, Non-Hodgkin 136 Leukemia, Myeloid, Acute 128 Carcinoma, Hepatocellular 124 Stomach Neoplasms 122 Lymphoma 112 Glioblastoma 109 Carcinoma, Renal Cell 107 Head and Neck Neoplasms 98 Squamous Cell Carcinoma of Head and Neck 96 Small Cell Lung Carcinoma 88 Lymphoma, Large B-Cell, Diffuse 88 Lymphoma, Follicular 88 Leukemia, Lymphocytic, Chronic, B-Cell 86 Leukemia 85 Brain Neoplasms 80 Carcinoma 69 Uterine Cervical Neoplasms 65 Sarcoma 64

Interventions

Sodium Chloride 1 Interleukin-7 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04426201 2024-04-11

ILIAD-7-US-O

Revimmune

Phase 2 Terminated

COVID-19, Lymphopenia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡